FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SOLANEZUMAB
异名/同义词IMMUNOGLOBULIN G1, ANTI-(HUMAN .BETA.-AMYLOID PEPTIDE) (HUMANIZED MONOCLONAL LY2062430 HEAVY CHAIN, DISULFIDE WITH HUMANIZED MONOCLONAL LY2062430 LIGHT CHAIN, DIMER)
IMMUNOGLOBULIN G1, ANTI-(HUMAN .BETA.-AMYLOID PEPTIDE) (HUMANIZED MONOCLONAL LY2062430 HEAVY CHAIN, DISULPHIDE WITH HUMANIZED MONOCLONAL LY2062430 LIGHT CHAIN, DIMER)
IMMUNOGLOBULIN G1, ANTI-(HUMAN .BETA.-AMYLOID) (HUMAN-MOUSE MONOCLONAL LY2062430 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL LY2062430 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN .BETA.-AMYLOID) (HUMAN-MOUSE MONOCLONAL LY2062430 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL LY2062430 LIGHT CHAIN, DIMER
LY2062430
LY-2062430
SOLANEZUMAB
SOLANEZUMAB [INN]
SOLANEZUMAB [JAN]
SOLANEZUMAB [WHO-DD]
CAS登记号955085-14-0
物质唯一标识(Unique Ingredient Identifier)5D6PWO0333
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System